COVID-19
Penington Institute is responding to the unfolding COVID-19/coronavirus outbreak by creating a series of informational resources for people who use drugs, their family and friends, and the sector.
These resources are […]
Annual Review 2019
Penington Institute’s look back at our work and accomplishments throughout last year. Download here.
International Overdose Awareness Day Partners’ Report 2019
This year’s International Overdose Awareness Day was the most successful yet. Download and read the Partners’ Report to learn more about our campaign.
Overdose and Response in Victoria – Seminar
Frontline initiatives to prevent fatal overdose in Victoria
Deaths from unintentional overdose are growing.
These deaths are, by definition, preventable. However, there are no silver bullets – sophisticated and evidence-based responses are […]
Life Savers global launch exposes opioid treatment
Penington Institute, the not-for-profit convenor of International Overdose Awareness Day, is today launching the website, Life Savers,1 a brief guide to treatment for people concerned about […]
Australia’s annual overdose report 2019 released
The toll of unintentional overdose deaths in Australia: Penington Institute
Australia’s Annual Overdose Report 2019 reveals that unintentional overdose continues to be a significant cause of death in Australia.
The continued growth in unintentional […]
Penington Institute calls for strong action on pregabalin (Lyrica®)
Lyrica®: Filling a pain fap or emerging threat? Penington institute recently hosted a public information forum with experts speakers discussing pregabalin (sold as Lyrica®). Subsidised as an antiepileptic […]
Australia’s dependence on prescription opioids should be new government’s top public health concern
One of the most urgent public health issues facing the new government will be Australia’s dependence on prescription opioids, independent drug research, policy and education organisation Melbourne-based Penington Institute, said […]
Lyrica®: Filling a pain gap or emerging threat?
Use of pregabalin (sold as Lyrica®) has skyrocketed in recent years. Anecdotal reports indicate problematic use is becoming more common including amongst people who inject drugs.
In Australia, pregabalin is a […]
Penington Institute reflects on the achievements of former PM Bob Hawke
Leading independent drug research, policy and education organisation, Penington Institute, has today celebrated the public health achievements of Australia’s 23rd Prime Minister the Hon RJL Hawke AC GCL on the […]
Penington Institute urges Canberra to show ‘courage, imagination and boldness’ in tackling Australia’s opioid death rate
Leading independent drug research, policy and education organisation, Penington Institute, has welcomed today’s (27 February) announcement by the Commonwealth Government that it will fund a $7.2 million trial of naloxone […]
Penington Institute’s Annual Review now available online
Penington Institute has launched its 2018 Annual Review, which is now available online.
